Month: February 2026

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

Written by Customer Service on February 20, 2026. Posted in Public Companies.

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that Psyence Labs Ltd., a leading developer and manufacturer of pharmaceutical-grade psychedelic compounds (“PsyLabs“) has exercised its rights under a previously disclosed put option agreement (the “Put Option Agreement“), pursuant to which Psyence BioMed will make an equity investment in PsyLabs at a fair market value determined in accordance with the terms of the Put Option Agreement. The Put Option Agreement was previously disclosed by Psyence BioMed and forms part of the broader strategic and commercial relationship between the two vertically integrated...

Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results

Written by Customer Service on February 20, 2026. Posted in Earnings Releases And Operating Results.

TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) announced on February 17, 2026 that it would be holding its fourth quarter conference call on March 10, 2026 at 8:00 am. Constellation has changed the date of the conference call to March 9, 2026 at 8:30 am. The Company’s quarterly results will be disseminated via press release, and made available on the Company’s website (www.csisoftware.com) and SEDAR+ (www.sedarplus.ca), at 7:00 am EST on Monday, March 9, 2026. Mark Miller, President, Jamal Baksh, Chief Financial Officer, and Bernard Anzarouth, Chief Investment Officer will be available during the March 9, 2026 conference call to answer questions regarding the Company’s results. To access the call, please dial 1-877-879-1183 (North America toll free) or 1-412-902-6703 (International) and using conference...

Razny Jewelers Acquires 109 East Oak Street, Significantly Expanding its Presence in Chicago’s Prestigious Luxury Corridor

Written by Customer Service on February 20, 2026. Posted in Mergers And Acquisitions.

Ownership of Two Oak Street Properties Solidifies Razny Jewelers’ Three Generations of Investment in Chicago and an Enduring Standard of Craftmanship, Service and TrustThe Razny Family, Owners of Razny JewelersRight to left: Michael Razny, Christine Razny-Porter, Stan Razny, Ingrid Razny and Eric Razny, second- and third-generation owners of Razny Jewelers.CHICAGO, Feb. 20, 2026 (GLOBE NEWSWIRE) — Razny Jewelers, Chicagoland’s most prominent family-owned and operated jeweler for 75 years, today announced it has completed the purchase of 109 East Oak Street, Chicago’s destination for luxury shopping. Financial terms of the transaction were not disclosed. The Razny family purchased the 7,500-square-foot, three-story retail building after assuming the lease in 2016. The property has remained under consistent ownership since...

iPower Reports Fiscal Q2 2026 Results and Completes Strategic Operating Reset

Written by Customer Service on February 20, 2026. Posted in Earnings Releases And Operating Results.

RANCHO CUCAMONGA, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”) today reported financial results for the fiscal second quarter ended December 31, 2025. Revenue was $7.1 million, reflecting the Company’s deliberate supply chain restructuring and transition to predominantly U.S.-based sourcing during the quarter, while gross profit was $3.1 million and gross margin remained strong at 44.0%. Total operating expenses declined 28% year-over-year to $5.6 million compared to the quarter ended December 31, 2024. Net loss attributable to iPower was $1.2 million, or $(1.08) per share. The Company reported $2.0 million of cash and cash equivalents, $2.2 million of restricted cash, and approximately $2.2 million of digital assets. During December 2025, the Company implemented a Digital Asset...

Abony Acquisition Corp. I Announces Closing of $230 Million Initial Public Offering Including Exercise of Underwriter’s Over-Allotment Option in Full

Written by Customer Service on February 20, 2026. Posted in Public Companies.

AUSTIN, TX, Feb. 20, 2026 (GLOBE NEWSWIRE) — Abony Acquisition Corp. I (Nasdaq: AACOU) (the “Company”) today announced the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriter of its over-allotment option in full, at a public offering price of $10.00 per unit. Each unit sold in the offering consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. The units are listed on the Global Market tier of the Nasdaq Stock Market LLC (“Nasdaq”) and commenced trading under the ticker symbol “AACOU” on February 19, 2026. Once the securities comprising the units begin separate trading, the Class...

Electra Upsizes At-The-Market Offering

Written by Customer Service on February 20, 2026. Posted in Public Companies.

TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) has announced that it has upsized its previously announced At the Market Offering Program (the “ATM”), pursuant to which the Company may offer and sell, at its discretion and from time to time, through H.C. Wainwright & Co., LLC (“Wainwright”), common shares in the capital of the Company (the “Common Shares”) having an aggregate offering price of up to US$25,000,000. The ATM was established pursuant to an At The Market Offering Agreement (the “ATM Agreement”) entered into with Wainwright and dated June 26, 2025. The US$25,000,000 aggregate offering amount includes the amount of sales previously made by the Company under the ATM Agreement pursuant to the Company’s prospectus supplement dated...

22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results

Written by Customer Service on February 20, 2026. Posted in Public Companies.

Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN® commercial expansion drives shift toward higher margin proprietary branded products MOCKSVILLE, N.C., Feb. 20, 2026 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced select, preliminary and unaudited financial results and operating metrics for the fourth quarter and full year ended December 31, 2025. The company anticipates releasing fourth quarter and full year 2025 earnings on or before March 31, 2026, and will host a conference call for investors and financial analysts. The final date and details of the conference call will separately...

U.S. Global Investors Reports 12% Sequential Growth in Assets Under Management in Q2 of Fiscal 2026

Written by Customer Service on February 20, 2026. Posted in Earnings Releases And Operating Results.

SAN ANTONIO, Feb. 20, 2026 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm1 with longstanding experience in global markets and specialized sectors, today reported financial results for the second quarter of fiscal 2026 ended December 31, 2025. Total assets under management (AUM) were approximately $1.5 billion at quarter-end, representing a 12% increase from the prior quarter and 5% higher than AUM at the end of the year-ago quarter. This rose to $1.7 billion in total AUM as of Thursday, February 19. Operating revenue increased by $259,000, or 11.5%, compared to the prior quarter, and by $279,000 compared to the quarter ended December 31, 2024. Additionally, the Company’s expenses decreased by $172,000 in the current quarter compared to the same quarter last year....

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

Written by Customer Service on February 20, 2026. Posted in Earnings Releases And Operating Results.

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed Acquisition by BioMarin Expected to Close in Q2 2026, Subject to Closing Conditions PRINCETON, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a leading, global biotechnology company with a clear and compelling mission to develop and deliver transformative medicines for people living with rare diseases, today announced financial results for the full year ended December 31, 2025. Full-Year 2025 Financial Highlights:Total revenues for the full year 2025 were $634.2 million, reflecting strong operational growth measured at constant exchange rates (CER)1 of 17% and a currency tailwind of ~$14 million. Fourth quarter total revenues were $185.2 million up 24%, or 20% at CER1.(in thousands) Three...

Surge Copper Announces Berg Project Acceptance into BC Critical Minerals Office

Written by Customer Service on February 20, 2026. Posted in Public Companies.

Vancouver, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) — Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to announce the British Columbia government’s acceptance of the Berg Project into the Critical Minerals Office (“CMO”). The Berg Project aligns with both national critical minerals objectives and the recently announced Western Canadian Critical Minerals Strategy, positioning the project within provincial and federal priorities to strengthen secure, responsibly produced mineral supply chains. If developed as envisioned, Berg’s projected output of critical minerals, including copper and molybdenum, would rank among the largest in Canada, reinforcing its strategic importance to British Columbia’s long-term economic and industrial objectives. Through the Critical...

Month: February 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals